Long-Term Trends In Acute Bronchodilator Responses Over 4 Years In Patients With Mild/moderate To Very Severe COPD: Post-Hoc Analysis Of Data From The Uplift Trial

被引：0
|
作者：
Tashkin, D. P. [1 ]
Li, N. [1 ]
Kleerup, E. [1 ]
Halpin, D. [2 ]
Decramer, M. [3 ]
Celli, B. R. [4 ]
Elashoff, R. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Royal Devon & Exeter Hosp, Exeter, Devon, England
[3] Univ Leuven, Leuven, Belgium
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5974
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: A post hoc analysis of efficacy and safety in Phase 3 and long-term extension studies over 7 years
    Chopra, Arvind
    Shobha, Vineeta
    Chandrashekara, Srikantiah
    Veeravalli, Sarath C. M.
    Sharma, Reena
    Rao, Uppuluri R.
    Pandya, Sapan
    Wagh, Shrikant
    Kadel, Jugal K.
    Thorat, Amit, V
    Adhav, Charles
    Estrella, Paul Santos
    Yu, Wei
    Kwok, Kenneth
    Wouters, Ann
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (07) : 882 - 897
  • [42] Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial
    Alexis, Andrew F.
    Deleuran, Mette
    Silverberg, Jonathan, I
    Gooderham, Melinda J.
    Farooqui, Saleem A.
    Chan, Gary
    Koppensteiner, Herwig
    Biswas, Pinaki
    Watkins, Melissa
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [43] Long-Term Safety, Efficacy, and Adherence of Tralokinumab for the Treatment of Patients with moderate to severe atopic Dermatitis over a Period of up to 3 Years: Interim Analysis of ECZTEND, a Phase III Long-Term Extension Study
    Wollenberg, Andreas
    Blauvelt, Andrew
    Lacour, Jean-Philippe
    Toth, Darryl
    Laquer, Vivian
    Herranz, Pedro
    Pink, Andrew
    Peris, Ketty
    Saeki, Hidehisa
    Beissert, Stefan
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 19 - 20
  • [44] Post-hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long-term study (Secondary Publication)
    Ishigooka, Jun
    Usami, Tomohiro
    Iwashita, Shuichi
    Kojima, Yoshitsugu
    Matsuo, Satoshi
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (02) : 122 - 129
  • [45] Long-Term Outcomes in Patients with Idiopathic Pulmonary Fibrosis (IPF) Split by Surgical Lung Biopsy (SLBx) Status: A Post-Hoc Analysis from the Pooled CAPACITY Studies
    Weigt, S.
    Gupta, S.
    Ko, J.
    Samara, K.
    Belperio, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [46] Rate of Severe COPD Exacerbations with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies: A Post-Hoc Analysis of the ETHOS Trial Excluding Data from China
    Ferguson, G. T.
    Rabe, K. F.
    Martinez, F. J.
    Wang, C.
    Trivedi, R.
    St Rose, E.
    Ballal, S.
    McLaren, J.
    Darken, P.
    Aurivillius, M.
    Dorinsky, P.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [47] Longitudinal Analysis of Respiratory Muscle Strength Recovery in Post-COVID-19 Patients: A Comparative Study of Acute and Long-Term Outcomes in Moderate to Severe Cases
    Goulart, Cassia
    Coutinho, Jean Carlos
    Da Costa, Ana Clara Goncalves
    Alves, Marcela Lopes
    Milani, Mauricio
    Borges, Robson Fernando
    Cleides, Ana
    De Oliveira, Luis Vicente Franco
    Da Silva, Vinicius Zacarias Maldaner
    Cipriano, Graziella Franca B.
    Cipriano Junior, Gerson
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [48] VEDOLIZUMAB TREATMENT PERSISTENCE UP TO 3 YEARS: POST HOC ANALYSIS IN VEDOLIZUMAB-NAIVE PATIENTS FROM THE GEMINI LONG-TERM SAFETY STUDY
    Loftus, Edward V.
    Vermeire, Severine
    Khalid, Javaria M.
    Tudor, David
    Akbari, Mona
    Demuth, Dirk
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2018, 154 (06) : S387 - S387
  • [49] Vedolizumab Treatment Persistence up to 5 Years: Post hoc Analysis in Vedolizumab-Naive Patients From the GEMINI Long-Term Safety Study
    Loftus, Edward, Jr.
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    Adsul, Sashi
    Demuth, Dirk
    Mokiou, Stella
    Patel, Haridarshan
    Lirio, Richard
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S14 - S15
  • [50] Maintenance of complete skin clearance throughout 3 years of continuous guselkumab treatment in patients with moderate-to-severe psoriasis: A post hoc analysis of 5-year data from the VOYAGE 1 trial
    Costanzo, Antonio
    Conrad, Curdin
    Gramiccia, Talia
    Jazra, Maria
    de Jong, Elke M. G. J.
    Iversen, Lars
    Ozturk, Bulent
    Wapenaar, Robert
    Wegner, Sven
    Torres, Tiago
    Puig, Luis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB108 - AB108
12345